Search results
Results From The WOW.Com Content Network
The company was launched in May 2006 as India's first mobile payments provider [1] that allowed consumers to use their mobile phones to pay for online and retail purchases, make utility bill payments, purchase tickets, etc. via their bank account, credit card or a prepaid account.
Merck & Co. was confiscated following the First World War and set up as an independent company in the United States. [14] [15] Today, the US company, which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, has about 68,000 employees (December 2021) in 120 countries. It is one of the top 5 pharmaceutical companies worldwide ...
Other players include fintech companies such as Paytm, Navi, Cred and Amazon Pay. PhonePe's share of UPI payments stood at 47.8% in November 2024 while Google Pay's share was at 37%, according to ...
Infibeam and Avenues (India) Private Limited entered into a binding agreement to merge and take control of CCAvenue through Equity Stake: NA [32] 2017: Acquisition: DRC Systems India Pvt Ltd: Infibeam Avenues acquired DRC Systems India Pvt Ltd, a company which provides software services for enterprise E-commerce, ERP and related fields: MoU [33 ...
For premium support please call: 800-290-4726 more ways to reach us
Paytm (an acronym for "pay through mobile") is an Indian multinational financial technology company, that specializes in digital payments and financial services, based in Noida, India. [4] Paytm was founded in 2010 by Vijay Shekhar Sharma under One97 Communications .
Mobile computing app that enables payment services. The Atom mobile app allows payments through debit and credit cards , IMPS , cash cards , and net banking Point of sale to provide payment services, Atom provides brick and mortar merchant, acquiring and transaction processing services, in addition to its services over the Internet, IVR and Mobile.
On Monday, Ligand Pharmaceuticals (NAS: LGND) confirmed that Merck (NYS: MRK) will pay it a $2 million milestone payment, as the latter begins phase 2b/3 clinical trials of a new cancer drug.